March 13, 2019
Chestnut Hill College will celebrate its 26th Annual Biomedical Distinguished Lecture Series on Wednesday, April 10 with a presentation on the difficulties of treating pancreatic cancer by Jonathan Brody, Ph.D. The event begins at 2 p.m. in the East Parlor of St. Joseph Hall and is free and open to the public.
Jonathan Brody, Ph.D.Dr. Jonathan Brody is the director of surgical research and co-director of
the Jefferson Pancreatic, Biliary and Related Cancer Center. He is also a
member of the Kimmel Center and a professor within Chestnut Hill College’s
surgery and pathology departments. His lab focuses on the many molecular
aspects of pancreatic cancer, including how to target a novel pro-survival
network in pancreatic cancer cells and optimize current therapies used in
the clinic. He has published more than 100 peer-review publications in many
top-tier scientific and cancer journals, and he has an interest in
personalizing therapy for pancreatic cancer patients.
Brody received his Ph.D. from Johns Hopkins University School of Medicine, and his thesis specialized in studying the molecular aspects of cancer and cancer genetics. He patented, along with Dr. Scott Kern, novel buffers for DNA identification that have changed the format of this molecular biology technique that is used to detect DNA. He was elected chair of the Cancer Research Program, Department of Defense Council, and he serves on many international study sections, including being the chair of the tumor biology and genomics study section for the American Cancer Society and NCI study section panels. Additionally, he was an American Cancer Society Research Scholar, and he is NIH funded and the winner of the 2010 American Association of Cancer Research’s Pancreatic Cancer Career Development Award.
Wednesday, April 10 at 2 p.m.
East Parlor of Saint Joseph Hall
9601 Germantown Ave
Philadelphia, PA 19118
Free and open to the public
More information
